Manufacturer record
Devbhoomi Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Devbhoomi Pharmaceuticals (Uttarakhand) were declared Not of Standard Quality between February 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GB25051, Fexofenadine Hydrochloride & Montelukast Sodium Tablets (exp Jan 2028). FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra State (state lab) found it not of standard quality: The Content of Montelukast. Listed in the September 2026 alert.
Records by type
4 records linked to Devbhoomi Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fexofenadine Hydrochloride & Montelukast Sodium Tablets | Batch GB25051Mfg Aug 2025 · Exp Jan 2028 | The Content of MontelukastOther | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
| Deflazacort Tablets 6 mg | Batch GT25943Mfg Sep 2025 · Exp Aug 2027 | Assay for DeflazacortAssay | RDTL, Bellary, KarnatakaState lab | Jun 2026 |
| (Fexofenadine Hydrochloride & Montelukast Sodium Tablets) | Batch GB25051Mfg Aug 2025 · Exp Jan 2028 | Assay for Montelukast onlyAssay | RDTL, Bellary, KarnatakaState lab | Mar 2026 |
| Drotaverine Hydrochloride Suspension | Batch OL25619Mfg Nov 2025 · Exp Oct 2027 | That the sample received does not conform to Manufactureres specification with respect to the test for Assay of Drotaverine HydrochlorideAssay | CDTL, MumbaiCDSCO lab | Feb 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.